Laboratory Medicine ›› 2022, Vol. 37 ›› Issue (11): 1039-1043.DOI: 10.3969/j.issn.1673-8640.2022.011.008
Previous Articles Next Articles
ZHAO Xiaomin, JIANG Xiaoyu, SHAN Kaili, SHAN Tieying, LIU Xiuzhen()
Received:
2021-05-20
Revised:
2022-05-20
Online:
2022-11-30
Published:
2022-12-26
Contact:
LIU Xiuzhen
CLC Number:
ZHAO Xiaomin, JIANG Xiaoyu, SHAN Kaili, SHAN Tieying, LIU Xiuzhen. Roles of Flt-3L,TF and 25(OH)D in iron deficiency anemia among infants and children[J]. Laboratory Medicine, 2022, 37(11): 1039-1043.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2022.011.008
组别 | 例数 | Hb/(g/L) | MCV/fL | MCH/pg | MCHC/(g/L) |
---|---|---|---|---|---|
正常对照组 | 100 | 125.14±11.42 | 87.46±3.85 | 39.22±3.64 | 352.61±8.37 |
非缺铁性贫血组 | 68 | 84.26±9.47* | 77.44±2.59* | 23.15±4.20* | 310.33±6.12* |
缺铁性贫血组 | 128 | 64.26±9.47*# | 64.78±4.29*# | 21.15±1.14*# | 232.15±9.64*# |
组别 | Flt-3L/(pg/mL) | TF/(μg/L) | 25(OH)D/(ng/mL) | SI/(mol/L) | |
正常对照组 | 25.41±5.84 | 2.98±0.69 | 33.16±5.16 | 17.30±2.40 | |
非缺铁性贫血组 | 25.41±5.84 | 3.01±1.43 | 29.12±4.22 | 15.10±3.50 | |
缺铁性贫血组 | 41.25±11.27*# | 11.42±1.52*# | 16.27±2.19*# | 6.30±0.23*# |
组别 | 例数 | Hb/(g/L) | MCV/fL | MCH/pg | MCHC/(g/L) |
---|---|---|---|---|---|
正常对照组 | 100 | 125.14±11.42 | 87.46±3.85 | 39.22±3.64 | 352.61±8.37 |
非缺铁性贫血组 | 68 | 84.26±9.47* | 77.44±2.59* | 23.15±4.20* | 310.33±6.12* |
缺铁性贫血组 | 128 | 64.26±9.47*# | 64.78±4.29*# | 21.15±1.14*# | 232.15±9.64*# |
组别 | Flt-3L/(pg/mL) | TF/(μg/L) | 25(OH)D/(ng/mL) | SI/(mol/L) | |
正常对照组 | 25.41±5.84 | 2.98±0.69 | 33.16±5.16 | 17.30±2.40 | |
非缺铁性贫血组 | 25.41±5.84 | 3.01±1.43 | 29.12±4.22 | 15.10±3.50 | |
缺铁性贫血组 | 41.25±11.27*# | 11.42±1.52*# | 16.27±2.19*# | 6.30±0.23*# |
组别 | 例数 | Flt-3L/(pg/mL) | TF/(μg/L) | 25(OH)D/(ng/L) | Hb/(g/L) |
---|---|---|---|---|---|
轻度贫血组 | 61 | 41.17±7.14 | 11.37±0.12 | 16.49±4.13 | 64.75±16.13 |
中度贫血组 | 55 | 42.63±8.35* | 12.26±0.47* | 15.34±2.16* | 52.18±11.24* |
重度贫血组 | 12 | 43.77±9.31*# | 13.09±0.43*# | 14.71±1.36*# | 35.29±9.63*# |
组别 | SI/(mol/L) | MCV/fL | MCH/pg | MCHC/(g/L) | |
轻度贫血组 | 7.70±0.53 | 69.53±10.11 | 21.81±3.13 | 246.15±9.54 | |
中度贫血组 | 6.90±0.20* | 66.38±9.55* | 20.77±3.25* | 235.29±7.79* | |
重度贫血组 | 6.10±0.14*# | 63.73±8.17*# | 17.52±2.64*# | 217.34±7.29*# |
组别 | 例数 | Flt-3L/(pg/mL) | TF/(μg/L) | 25(OH)D/(ng/L) | Hb/(g/L) |
---|---|---|---|---|---|
轻度贫血组 | 61 | 41.17±7.14 | 11.37±0.12 | 16.49±4.13 | 64.75±16.13 |
中度贫血组 | 55 | 42.63±8.35* | 12.26±0.47* | 15.34±2.16* | 52.18±11.24* |
重度贫血组 | 12 | 43.77±9.31*# | 13.09±0.43*# | 14.71±1.36*# | 35.29±9.63*# |
组别 | SI/(mol/L) | MCV/fL | MCH/pg | MCHC/(g/L) | |
轻度贫血组 | 7.70±0.53 | 69.53±10.11 | 21.81±3.13 | 246.15±9.54 | |
中度贫血组 | 6.90±0.20* | 66.38±9.55* | 20.77±3.25* | 235.29±7.79* | |
重度贫血组 | 6.10±0.14*# | 63.73±8.17*# | 17.52±2.64*# | 217.34±7.29*# |
项目 | β值 | 标准误 | Wald值 | P值 | OR值(95%CI) |
---|---|---|---|---|---|
Flt-3L | 1.463 | 0.527 | 7.707 | 0.006 | 4.319(1.537~12.133) |
TF | 1.507 | 0.433 | 12.113 | 0.001 | 4.513(1.932~10.545) |
25(OH)D | 1.628 | 0.654 | 6.197 | 0.013 | 5.094(1.414~18.354) |
Hb | 1.021 | 0.631 | 2.618 | 0.106 | 2.776(0.806~9.526) |
SI | 0.932 | 0.511 | 3.327 | 0.069 | 2.540(0.933~6.914) |
MCV | 0.814 | 0.496 | 2.693 | 0.102 | 2.257(0.854~5.966) |
MCH | 0.612 | 0.397 | 2.376 | 0.124 | 1.844(0.847~4.015) |
MCHC | 0.702 | 0.387 | 3.290 | 0.070 | 2.018(0.945~4.308) |
项目 | β值 | 标准误 | Wald值 | P值 | OR值(95%CI) |
---|---|---|---|---|---|
Flt-3L | 1.463 | 0.527 | 7.707 | 0.006 | 4.319(1.537~12.133) |
TF | 1.507 | 0.433 | 12.113 | 0.001 | 4.513(1.932~10.545) |
25(OH)D | 1.628 | 0.654 | 6.197 | 0.013 | 5.094(1.414~18.354) |
Hb | 1.021 | 0.631 | 2.618 | 0.106 | 2.776(0.806~9.526) |
SI | 0.932 | 0.511 | 3.327 | 0.069 | 2.540(0.933~6.914) |
MCV | 0.814 | 0.496 | 2.693 | 0.102 | 2.257(0.854~5.966) |
MCH | 0.612 | 0.397 | 2.376 | 0.124 | 1.844(0.847~4.015) |
MCHC | 0.702 | 0.387 | 3.290 | 0.070 | 2.018(0.945~4.308) |
项目 | AUC | P值 | 最佳临界值 | 敏感性/% | 特异性/% | Youden指数 |
---|---|---|---|---|---|---|
Flt-3L | 0.860 | 0.000 | 35.56 pg/mL | 68.0 | 96.0 | 0.563 |
TF | 0.854 | 0.000 | 3.87 μg/L | 72.7 | 90.0 | 0.512 |
25(OH)D | 0.897 | 0.000 | 29.33 ng/mL | 98.4 | 76.0 | 0.635 |
联合检测 | 0.983 | 0.000 | 0.513 | 93.0 | 95.0 | 0.814 |
项目 | AUC | P值 | 最佳临界值 | 敏感性/% | 特异性/% | Youden指数 |
---|---|---|---|---|---|---|
Flt-3L | 0.860 | 0.000 | 35.56 pg/mL | 68.0 | 96.0 | 0.563 |
TF | 0.854 | 0.000 | 3.87 μg/L | 72.7 | 90.0 | 0.512 |
25(OH)D | 0.897 | 0.000 | 29.33 ng/mL | 98.4 | 76.0 | 0.635 |
联合检测 | 0.983 | 0.000 | 0.513 | 93.0 | 95.0 | 0.814 |
项目 | AUC | P值 | 最佳临界值 | 敏感性/% | 特异性/% | Youden指数 |
---|---|---|---|---|---|---|
Flt-3L | 0.797 | 0.000 | 33.65 pg/mL | 61.7 | 97.1 | 0.496 |
TF | 0.821 | 0.000 | 3.70 μg/L | 82.8 | 69.1 | 0.573 |
25(OH)D | 0.862 | 0.000 | 26.19 ng/mL | 82.8 | 82.4 | 0.702 |
联合检测 | 0.981 | 0.000 | 0.479 | 91.4 | 95.6 | 0.805 |
项目 | AUC | P值 | 最佳临界值 | 敏感性/% | 特异性/% | Youden指数 |
---|---|---|---|---|---|---|
Flt-3L | 0.797 | 0.000 | 33.65 pg/mL | 61.7 | 97.1 | 0.496 |
TF | 0.821 | 0.000 | 3.70 μg/L | 82.8 | 69.1 | 0.573 |
25(OH)D | 0.862 | 0.000 | 26.19 ng/mL | 82.8 | 82.4 | 0.702 |
联合检测 | 0.981 | 0.000 | 0.479 | 91.4 | 95.6 | 0.805 |
[1] | 麦文英, 谢笑英, 廖桂桃, 等. 儿童保健门诊婴幼儿营养性缺铁性贫血临床分析[J]. 当代医学, 2015, 21(2):114-115. |
[2] | 赵育军, 陈淑贞, 邝珠兰. 微信教育团队引导健康教育延续医疗服务应用于0-3岁婴幼儿缺铁性贫血效果观察[J]. 海南医学, 2020, 31(6):748-750. |
[3] | 刘建欣, 刘桂玲, 李燕燕, 等. 中国2000-2020年0-14岁儿童缺铁性贫血患病率的Meta分析[J]. 中国学校卫生, 2020, 41(12):1876-1881. |
[4] | 傅晋翔, 施小凤, 李军, 等. Flt3配体促进再生障碍性贫血患者淋巴细胞向T_H1表型分化[J]. 中华微生物学和免疫学杂志, 2004, 24(1):28-31. |
[5] | 黄永兰, 黄绍良, 梁蔚文, 等. 再生障碍性贫血患儿CD_4~+CD_(25)~+T细胞及TGF-β1 Flt-3L水平变化的意义[J]. 中国实用儿科杂志, 2007, 22(2):130-133. |
[6] | 刘朝阳, 徐帆洪. FLT3配体研究进展[J]. 国际生物制品学杂志, 2008, 31(3):128-132. |
[7] | 赵凤华. 血清铁、铁蛋白、转铁蛋白联合检测在儿童营养性缺铁性贫血筛查中的价值[J]. 中国妇幼保健, 2018, 33(24):5833-5835. |
[8] | 郭平, 姚欢迎. 小儿营养性缺铁性贫血的相关因素分析[J]. 中华全科医学, 2018, 16(2):257-259. |
[9] | 杨光辉. 多种铁剂治疗小儿缺铁性贫血的临床疗效差异比较[J]. 世界最新医学信息文摘, 2018, 18(4):84. |
[10] | 中华医学会血液学分会红细胞疾病贫血学组. 铁缺乏症和缺铁性贫血诊治和预防多学科专家共识[J]. 中华医学杂志, 2018, 98(28):2233-2237. |
[11] | 高举. 儿童缺铁和缺铁性贫血防治建议[J]. 中华儿科杂志, 2008, 59(7):502-504. |
[12] | 杨文凯, 陈虹. 婴幼儿缺铁性贫血现况、影响因素及其对智力发育的影响[J]. 西北国防医学杂志, 2018, 39(2):126-130. |
[13] | 廖鸣慧. 儿童营养性维生素D缺乏性佝偻病合并缺铁性贫血的临床治疗分析[J]. 实用临床医药杂志, 2018, 22(13):74-76. |
[14] | KILCI C, OLCAY L, ÖZDEMIR B, et al. Children with iron deficiency anemia have a tendency to hypercoagulation:an evaluation by thromboelastography[J]. Turk J Haematol, 2020, 37(1):59-62. |
[15] |
KARIM T J, PAUL D J, TROXELL R M, et al. Infant with protein C deficiency and stroke in the setting of iron deficiency anemia[J]. Clin Case Rep, 2019, 7(9):1655-1659.
DOI URL |
[16] | 张海艳, 唐朝亮, 宋文仕, 等. 维生素AD联合铁剂治疗婴幼儿缺铁性贫血的效果[J]. 临床与病理杂志, 2020, 40(4):882-886. |
[17] |
PRIETO-PATRON A, V HUTTON Z, FATTORE G, et al. Reducing the burden of iron deficiency anemia in Cote D'Ivoire through fortification[J]. J Health Popul Nutr, 2020, 39(1):1.
DOI URL |
[18] | 赵凤华. 血清铁、铁蛋白、转铁蛋白联合检测在儿童营养性缺铁性贫血筛查中的价值[J]. 中国妇幼保健, 2018, 33(24):5833-5835. |
[19] |
ZHANG J, TANG W. Building a prediction model for iron deficiency anemia among infants in Shanghai,China[J]. Food Sci Nutr, 2019, 8(1):265-272.
DOI URL |
[20] |
SUNDARARAJAN S, RABE H. Prevention of iron deficiency anemia in infants and toddlers[J]. Pediatr Res, 2021, 89(1):63-73.
DOI URL |
[21] | 陈龙梅, 刘万超, 张丽丽, 等. 各红细胞参数在缺铁性贫血鉴别中的应用[J]. 实用医学杂志, 2019, 35(8):1331-1335. |
[22] |
KARASKOVA E, POSPISILOVA D, VELGANOVA-VEGHOVA M, et al. Importance of hepcidin in the etiopathogenesis of anemia in inflammatory bowel disease[J]. Dig Dis Sci, 2021, 66(10):3263-3269.
DOI URL |
[1] | LIU Yang, GENG Kunjing, LI Hongjiang, SHI Haoxi, CHEN Sisi. Relationship of 25(OH)D3 and liver inflammatory stage with the efficacy of antiviral therapy [J]. Laboratory Medicine, 2022, 37(7): 628-631. |
[2] | ZHANG Zhibin, YANG Wanyong, RUAN Fuwang, WEN Qinghui. Roles of total IgE,sIgE and 25(OH)D in the evaluation of infant atopic dermatitis [J]. Laboratory Medicine, 2022, 37(3): 217-220. |
[3] | LI Dingfu, HUANG Jian, CAI Meiling, WANG Lizhen, JIAN Kaigan, YANG Feifei. Relationship between serum 25(OH)D and disease control in children with allergic rhinitis-asthma syndrome [J]. Laboratory Medicine, 2022, 37(1): 32-35. |
[4] | ZHAO Xueling, ZHENG Xin, XU Huamei, SHI Hongyao. Correlation between serum 25(OH)D,specific IgE and VAS score in children with allergic rhinitis [J]. Laboratory Medicine, 2021, 36(6): 615-617. |
[5] | LI Bingling, CHENG Yating, ZHAO Beibei, SHE Xuhui, DONG Heng, YU Mujun. Evaluation of surrogate matrices for serum 25-hydroxyvitamin D calibrators by LC-MS/MS [J]. Laboratory Medicine, 2021, 36(2): 213-218. |
[6] | FANG Huiling, GE Danhong, ZHU Yuqing, ZHU Lingfeng, ZHAO Xiaojun, CHEN Ziqi, WANG Zimeng. Analysis on the external quality assessment results for 25-hydroxyvitamin D of Shanghai from 2015 to 2019 [J]. Laboratory Medicine, 2021, 36(2): 219-224. |
[7] | CHEN Gang, WANG Jing, DENG Qiang, CHEN Xi, HU Dong, ZHUANG Lidong. Correlation and risk assessment of serum 25(OH)D level and multiple thyroid function indicators in patients with thyroid cancer before operation [J]. Laboratory Medicine, 2020, 35(9): 885-888. |
[8] | ZHANG Sujie, JU Yi, LI Qing, SUN Hewei, FENG Xueqing, JIN Zhonggan, LI Shuijun, LI Yujie, LI Jinrong. Analysis of serum 25-hydroxyvitamin D levels in healthy subjects [J]. Laboratory Medicine, 2020, 35(10): 1028-1031. |
[9] | SUN Liangbo, JING Haining. Correlation of bioavailable 1,25(OD)2D level with bone mineral density and bone metabolic markers in patients with nephrotic syndrome [J]. Laboratory Medicine, 2019, 34(8): 717-721. |
[10] | GUAN Wenqian, GAO Chunfang. Research progress of human serum transferrin glycosylation [J]. Laboratory Medicine, 2019, 34(6): 563-566. |
[11] | ZHOU Chunlei, CHEN Ruping, WANG Kai, GAO Qiang, MU Hong. Role of serum soluble transferrin receptor in the diagnosis of adult iron deficiency anemia [J]. Laboratory Medicine, 2019, 34(11): 1002-1006. |
[12] | LIN Xiangquan, CHEN Hong. Roles of serum 25-hydroxyvitamin D and bone mineral density in children with obesity [J]. Laboratory Medicine, 2018, 33(8): 669-673. |
[13] | LUO Qingxin, CHEN Kaiting, LAN Yanling, MO Xin, CHEN Jiaqiang. Additive effect of serum 25-hydroxyvitamin D3 in the treatment of depression [J]. Laboratory Medicine, 2018, 33(6): 491-494. |
[14] | LI Yaju, CHEN Kun, GUAN Ming. Roles of 25-hydroxyvitamin D levels and related indicators for inflammatory myopathy [J]. Laboratory Medicine, 2018, 33(5): 411-415. |
[15] | ZHANG Mingxu, DING Xiaoling, LI Lei. Comparison on 25-hydroxyvitamin D levels between pregnant and non-pregnant childbearing age women [J]. Laboratory Medicine, 2017, 32(9): 753-756. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||